ID   HepG2-N10
AC   CVCL_A8IF
SY   HepN10
DR   BTO; BTO:0006301
DR   cancercelllines; CVCL_A8IF
DR   Wikidata; Q107115336
RX   PubMed=18313149;
CC   From: Xia N.-S.; Xiamen University; Xiamen; China.
CC   Population: Caucasian.
CC   Virology: Transfected with a hepatitis B virus (HBV) subtype adw2 genome.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
RX   PubMed=18313149; DOI=10.1016/j.antiviral.2007.11.011;
RA   Xu J., Wang J., Deng F., Hu Z.-H., Wang H.-L.;
RT   "Green tea extract and its major component epigallocatechin gallate
RT   inhibits hepatitis B virus in vitro.";
RL   Antiviral Res. 78:242-249(2008).
//